Production (Stage)
OnKure Therapeutics, Inc.
OKUR
$2.88
$0.020.70%
NASDAQ
| 03/31/2025 | 12/31/2024 | 06/30/2024 | 03/31/2024 | ||
|---|---|---|---|---|---|
| Net Income | -67.00% | -84.47% | -72.79% | -9.87% | |
| Total Depreciation and Amortization | 40.40% | 66.40% | -4.52% | 17.97% | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | 2,465.42% | 2,553.92% | 9,972.22% | 664.29% | |
| Change in Net Operating Assets | 23.24% | -500.41% | 285.01% | -133.91% | |
| Cash from Operations | -31.76% | -232.68% | 41.65% | -133.45% | |
| Capital Expenditure | -100.00% | 54.55% | 83.33% | 18.18% | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -- | -- | -- | -- | |
| Cash from Investing | -100.00% | 48,312.12% | 83.33% | 18.18% | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -- | -- | -- | -- | |
| Issuance of Common Stock | -- | 654,144.44% | 66.67% | -75.61% | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -- | 5,136,300.00% | -1,675.00% | -- | |
| Cash from Financing | -870.00% | 1,102,360.00% | 293,500.00% | -99.98% | |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -32.67% | 1,559.63% | 94.49% | -121.89% | |